Gujarat Inject (Kerala) share news, announcements and annual reports
BSE: 524238Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹11.22.
30 Oct: open ₹11.29, high ₹11.54, low ₹10.77
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹163 Cr2,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 54.64
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.82
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 32.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,44,603
Gujarat Inject (Kerala) share news and announcements
407 announcements, routine notices left out, newest first. Page 4 of 9.
Nov 2023
Oct 2023
26 Oct · Board meeting
Meeting on 3 Nov 2023: preferential issue of shares and quarterly resultsNot held on this date
Sep 2023
Aug 2023
11 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results
May 2023
24 May · Non-Applicability Of The Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
15 May · Board meeting
Meeting on 22 May 2023: quarterly results and audited results10 May · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Apr 2023
17 Apr · Submission Of Compliance Certificate In Pursuance Of Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
17 Apr · Revised Certificate Of Practicing Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
15 Apr · Submission Of Certificate Of Practicing Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Mar 2023
31 Mar · Board meeting
Meeting on 31 Mar 2023
Feb 2023
3 Feb · Board meeting
Meeting on 10 Feb 2023: quarterly results
Nov 2022
2 Nov · Board meeting
Meeting on 10 Nov 2022: quarterly results
Oct 2022
31 Oct · Board meeting
Meeting on 31 Oct 202231 Oct · Board meeting
14 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
14 Sep · Announcement under Regulation 30 (LODR)-Issue of Securities
7 Sep · Board meeting
Meeting on 14 Sep 2022: issue of warrants5 Sep · Board meeting
Meeting on 7 Sep 2022: issue of warrants
Aug 2022
8 Aug · Board meeting
Meeting on 13 Aug 2022: quarterly results
Jul 2022
29 Jul · Board meeting
Meeting on 29 Jul 2022